/ Print /

Judith M. Orvos, ELS
Judith M. Orvos, ELS, is a a BELS-certified medical writer and editor and an editorial consultant for Contemporary OB/GYN.
Are vaginal estradiol tablets better for VVS than OTC moisturizer or placebo?
Results of a randomized clinical trial (RCT) suggest that over-the-counter moisturizer may be just as effective as vaginal estrogen tablets for treatment of vulvovaginal symptoms (VVS) in postmenopausal women. Plus: Does a Mediterranean diet help protect bones in postmenopausal women? Also: Metformin, an oral diabetes medication, seems to reduce the likelihood of late miscarriage and premature birth in women with polycystic ovary syndrome (PCOS), according to results of a multicenter study.
IVF storage tank failures spark reviews, lawsuits
Failure of liquid nitrogen storage tanks at two major infertility centers has led to a review of procedures at those and other similar facilities by them and the American Society for Reproductive Medicine (ASRM). Plus: Does MHT affect cardiovascular health? Also: Hirsutism treatment and diagnosis updated.
USPSTF: Ovarian cancer screening not recommended for low-risk women
In a new statement, the US Preventive Services Task Force (USPSTF) is recommending against ovarian cancer screening for women who have no symptoms and no hereditary cancer syndromes. Plus: Breast MRI screening results in higher biopsy rates, according to a study.
Drug used for menorrhagia may prevent postpartum hemorrhage
A drug that is low cost and easy to administer may help prevent maternal deaths, according to results of a randomized clinical trial. Plus: Does air pollution affect menstrual regularity? Also: According to a statement published by the American Heart Association (AHA), breast cancer patients may be at increased risk of cardiovascular disease (CVD).
US initiatives to reduce maternal mortality globally
To help combat maternal mortality rates globally, the US government has invested more than $15 billion since 2008 in innovative measures to accelerate reduction in deaths. These efforts are led by the US Agency for International Development (USAID).
Study: Rare type of stroke may be increasing in pregnant women
Preliminary data from a retrospective study suggest that incidence of spontaneous subarachnoid hemorrhage (sSAH) may be increasing among pregnant women. Plus: Study finds lower risk of diabetes a benefit of breastfeeding. Also: Taking prenatal folic acid and multivitamins lowers the risk of autism, according to results of a new case-control study.
ARRIVE study: 39-week induction reduces frequency of cesarean in healthy women
Results of a large randomized clinical trial indicate that in low-risk nulliparas, elective induction of labor (IOL) at 39 weeks lowers rates of cesarean delivery (CD) without significantly increasing adverse perinatal outcomes. Plus, more coverage from The Pregnancy Meeting.
What impact does maternal obesity have on fetal growth?
Results of a study of fetal ultrasounds show that maternal obesity has an impact on fetal growth as early as 32 weeks’ gestation. Plus: Breast cancer risks increased by 21% in women who consumed more than 9 g of processed meat per day, according to a published study. Also: Does prenatal use of topiramate increase risk of cleft palate?
FDA: New assessment discourages morcellation for fibroids
An updated review of evidence by the US Food and Drug Administration (FDA) underscores concerns expressed in 2014 by the agency about use of laparoscopic power morcellators (LPM) for treatment of uterine fibroids. Plus: Prescription habits show ob/gyns not well informed about opioids, according to a study. Also: Does ADHD medication use during pregnancy increase risk of congenital malformations?
Hormonal contraception and breast cancer: Is there a link?
Results of a prospective cohort study by Danish investigators suggest that current or recent use of hormonal contraceptives may be associated with an increased risk of breast cancer. Plus, Editorial Board Member, Ilana Cass, MD, weighs in on the impact of the study's findings.